Operating Expenses Summary of Center Laboratories, Inc.

Center Laboratories, Inc.'s latest annual operating expenses in 2023 was 697.35 Million TWD , up 472.38% from previous year.
Center Laboratories, Inc.'s latest quarterly operating expenses in 2024 Q2 was 134.85 Million TWD , up 9.95% from previous quarter.
Center Laboratories, Inc. reported a annual operating expenses of 121.83 Million TWD in annual operating expenses 2022, down -76.29% from previous year.
Center Laboratories, Inc. reported a annual operating expenses of 513.81 Million TWD in annual operating expenses 2021, down -37.58% from previous year.
Center Laboratories, Inc. reported a quarterly operating expenses of 122.65 Million TWD for 2024 Q1, down -34.17% from previous quarter.
Center Laboratories, Inc. reported a quarterly operating expenses of 148.3 Million TWD for 2023 Q2, up 15.12% from previous quarter.

Annual Operating Expenses Chart of Center Laboratories, Inc. (2023 - 2006)

Historical Annual Operating Expenses of Center Laboratories, Inc. (2023 - 2006)

Year	Operating Expenses	Operating Expenses Growth
2023	697.35 Million TWD	472.38%
2022	121.83 Million TWD	-76.29%
2021	513.81 Million TWD	-37.58%
2020	823.1 Million TWD	16.13%
2019	708.79 Million TWD	-92.16%
2018	9.04 Billion TWD	19.57%
2017	7.56 Billion TWD	29.88%
2016	5.82 Billion TWD	136.78%
2015	2.45 Billion TWD	472.57%
2014	429.48 Million TWD	36.02%
2013	315.75 Million TWD	-4.33%
2012	330.04 Million TWD	24.17%
2011	265.8 Million TWD	2.37%
2010	259.64 Million TWD	31.68%
2009	197.17 Million TWD	48.94%
2008	132.38 Million TWD	31.83%
2007	100.42 Million TWD	7.62%
2006	93.31 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	134.85 Million TWD	9.95%
2024 Q1	122.65 Million TWD	-34.17%
2023 Q2	148.3 Million TWD	15.12%
2023 Q4	186.3 Million TWD	60.28%
2023 Q3	116.24 Million TWD	-21.62%
2023 FY	697.35 Million TWD	472.38%
2023 Q1	128.82 Million TWD	-9.72%
2022 Q3	70.66 Million TWD	2648.35%
2022 Q2	2.57 Million TWD	102.73%
2022 Q4	142.69 Million TWD	101.94%
2022 FY	121.83 Million TWD	-76.29%
2022 Q1	-94.09 Million TWD	-306.58%
2021 FY	513.81 Million TWD	-37.58%
2021 Q3	-88.91 Million TWD	-140.49%
2021 Q4	-23.14 Million TWD	73.97%
2021 Q2	219.58 Million TWD	-45.95%
2021 Q1	406.28 Million TWD	84.43%
2020 Q4	220.28 Million TWD	-39.22%
2020 Q3	362.45 Million TWD	292.71%
2020 Q2	92.29 Million TWD	-37.67%
2020 FY	823.1 Million TWD	16.13%
2020 Q1	148.06 Million TWD	-35.74%
2019 FY	708.79 Million TWD	-92.16%
2019 Q2	179.3 Million TWD	26.69%
2019 Q3	157.54 Million TWD	-12.13%
2019 Q4	230.4 Million TWD	46.24%
2019 Q1	141.53 Million TWD	-88.66%
2018 Q2	2.77 Billion TWD	16.93%
2018 FY	9.04 Billion TWD	19.57%
2018 Q4	1.24 Billion TWD	-52.88%
2018 Q3	2.64 Billion TWD	-4.51%
2018 Q1	2.37 Billion TWD	-7.0%
2017 Q4	2.55 Billion TWD	31.15%
2017 FY	7.56 Billion TWD	29.88%
2017 Q2	1.66 Billion TWD	19.07%
2017 Q3	1.94 Billion TWD	16.67%
2017 Q1	1.39 Billion TWD	-28.42%
2016 Q4	1.95 Billion TWD	50.09%
2016 FY	5.82 Billion TWD	136.78%
2016 Q3	1.3 Billion TWD	-6.14%
2016 Q2	1.38 Billion TWD	18.14%
2016 Q1	1.17 Billion TWD	-16.27%
2015 FY	2.45 Billion TWD	472.57%
2015 Q1	111.23 Million TWD	-23.1%
2015 Q3	797.69 Million TWD	444.33%
2015 Q4	1.4 Billion TWD	75.96%
2015 Q2	146.54 Million TWD	31.75%
2014 Q3	94.58 Million TWD	-10.36%
2014 FY	429.48 Million TWD	36.02%
2014 Q4	144.64 Million TWD	52.92%
2014 Q2	105.52 Million TWD	24.52%
2014 Q1	84.74 Million TWD	-2.44%
2013 Q3	82.09 Million TWD	6.25%
2013 FY	315.75 Million TWD	-4.33%
2013 Q1	69.53 Million TWD	-19.28%
2013 Q2	77.27 Million TWD	11.13%
2013 Q4	86.85 Million TWD	5.79%
2012 Q4	86.13 Million TWD	2.83%
2012 FY	330.04 Million TWD	24.17%
2012 Q1	68.46 Million TWD	7.37%
2012 Q2	91.9 Million TWD	34.24%
2012 Q3	83.76 Million TWD	-8.87%
2011 Q3	63.25 Million TWD	-7.08%
2011 Q4	63.76 Million TWD	0.82%
2011 FY	265.8 Million TWD	2.37%
2011 Q1	70.71 Million TWD	-9.55%
2011 Q2	68.07 Million TWD	-3.73%
2010 Q1	57.08 Million TWD	0.0%
2010 Q2	59.18 Million TWD	3.68%
2010 Q4	78.17 Million TWD	19.89%
2010 FY	259.64 Million TWD	31.68%
2010 Q3	65.2 Million TWD	10.18%
2009 FY	197.17 Million TWD	48.94%
2008 FY	132.38 Million TWD	31.83%
2007 FY	100.42 Million TWD	7.62%
2006 FY	93.31 Million TWD	0.0%

Peer Operating Expenses Comparison of Center Laboratories, Inc.

Name	Operating Expenses	Operating Expenses Difference
Allied Biotech Corporation	157.72 Million TWD	-342.136%
GeneFerm Biotechnology Co., Ltd.	132.78 Million TWD	-425.175%
Easywell Biomedicals, Inc.	333.45 Million TWD	-109.131%
TTY Biopharm Company Limited	1.91 Billion TWD	63.52%
Synmosa Biopharma Corporation	1.49 Billion TWD	53.497%
Orient EuroPharma Co., Ltd.	2.14 Billion TWD	67.523%
Tien Liang BioTech Co., Ltd.	267.27 Million TWD	-160.915%
Orient Pharma Co., Ltd.	468.66 Million TWD	-48.796%
InnoPharmax Inc.	82.29 Million TWD	-747.379%
Johnson Chemical Pharmaceutical Works Co., Ltd.	244.63 Million TWD	-185.063%
Excelsior Biopharma Inc.	388.05 Million TWD	-79.705%
DV Biomed Co., Ltd.	575.24 Million TWD	-21.229%
Foresee Pharmaceuticals Co., Ltd.	1.12 Billion TWD	37.825%
Handa Pharmaceuticals, Inc.	399.14 Million TWD	-74.711%
UniPharma Co., Ltd.	78.32 Million TWD	-790.386%
Anxo Pharmaceutical Co., Ltd.	396.93 Million TWD	-75.686%
Alar Pharmaceuticals Inc.	83.74 Million TWD	-732.717%
Winston Medical Supply Co., Ltd.	151.49 Million TWD	-360.312%
Mercury Biopharmaceutical Corporation	592 Thousand TWD	-117697.128%
Bioray Biotech Co., Ltd	96.98 Million TWD	-619.06%
TSH Biopharm Corporation Limited	336.26 Million TWD	-107.381%

Global Stocks Search

Center Laboratories, Inc. (4123.TWO)

Operating Expenses Summary of Center Laboratories, Inc.

Annual Operating Expenses Chart of Center Laboratories, Inc. (2023 - 2006)

Historical Annual Operating Expenses of Center Laboratories, Inc. (2023 - 2006)

Peer Operating Expenses Comparison of Center Laboratories, Inc.